Mechanisms of Effort Intolerance in Patients With Rheumatic Mitral Stenosis: Combined Echocardiography and Cardiopulmonary Stress Protocol.

Psoriatic ArthritisRheumatoid Arthritis

Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain

Patient Prefer Adherence.

Nolla JM, Rodríguez M, Martin-Mola E, Raya E, Ibero I, Nocea G, Aragon B, Lizán L, Prades M

doi: 10.2147/PPA.S106311.

Rheumatoid Arthritis

Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: sub-analysis of the Swiss and Austrian patients from the ACT-SURE study

Clin Rheumatol.

Mueller RB, Graninger W, Sidiropoulos P, Goger C, von Kempis J

doi: 10.1007/s10067-017-3779-2.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Semin Arthritis Rheum.

Michelena X, Borrell H, López-Corbeto M, López-Lasanta M, Moreno E, Pascual-Pastor M, Erra A, Serrat M, Espartal E, Antón S, Añez GA, Caparrós-Ruiz R, Pluma A, Trallero-Araguás E, Barceló-Bru M, Almirall M, De Agustín JJ, Segura JL, Julià A, Marsal S

doi: 10.1016/j.semarthrit.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'

Ann Rheum Dis.

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS

doi: 10.1136/annrheumdis-2020-217888.

Prognosis of patients with rheumatic diseases admitted to intensive care.

Anaesth Intensive Care.

Beil M, Sviri S, de la Guardia V, Stav I, Ben-Chetrit E, van Heerden PV

Melanoma and Skin CancerRheumatoid Arthritis

Baricitinib, Methotrexate, or Combination in Patients with Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment

Arthritis Rheumatol.

Fleischmann R, Schiff M, van der Heijde D, Ramos-Remus C, Spindler A, Stanislav M, Zerbini CA, Gurbuz S, Dickson C, de Bono S, Schlichting D, Beattie S, Kuo WL, Rooney T, Macias W, Takeuchi T

doi: 10.1002/art.39953.

Immunodeficiency

Survey of Infection Control Precautions for Patients with Severe Combined Immune Deficiency

J Clin Immunol.

Dergousoff BA, Vayalumkal JV, Wright NAM

doi: 10.1007/s10875-019-00671-y.

Psoriatic Arthritis

The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis

Semin Arthritis Rheum.

Zhou W, Chandran V, Cook R, Gladman DD, Eder L

doi: 10.1016/

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

COVID-19 in rheumatic disease patients on immunosuppressive agents

Semin Arthritis Rheum.

Sharmeen S, Elghawy A, Zarlasht F, Yao QP

doi: 10.1016/j.semarthrit.2020.05.010.

Related content

Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'

Prognosis of patients with rheumatic diseases admitted to intensive care.

Baricitinib, Methotrexate, or Combination in Patients with Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment

Survey of Infection Control Precautions for Patients with Severe Combined Immune Deficiency

The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis

COVID-19 in rheumatic disease patients on immunosuppressive agents